← Leaderboards
Natasha Bassam Halasa
Vanderbilt University Medical Center
$37,609,939
Attributed
$43,208,176
Total exposure
14
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,221,841 · 12
CDC$20,710,027 · 3
By mechanism
U01$41,024,634 · 11
U24$3,800,000 · 1
R21$467,500 · 1
K23$372,114 · 1
R34$267,620 · 1
Top collaborators
- Lara A Danziger-Isakov3 shared
- Suman Ranjan Das1 shared
- Simon Alexander Mallal1 shared
- John Alan Mclean1 shared
- Ravi Shah1 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Jeffrey M Spraggins$21,090,147
- Kevin L Schey$22,315,595
- Michael Rutledge Debaun$40,846,229
- Mahmoud Umar Sani$1,332,668
- Clarence Buddy Creech$64,037,457
Others in their field
Top investigators on “Site”
- Lawrence Corey · Fred Hutchinson Cancer Center$727,416,881
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$630,131,001
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
SiteVaccinesFrequenciesResponseSeveritiesDoseAdverse EventAntigensRandomizedEnrollmentImmune ResponseSafetyInfluenzavirusInfluenza Virus VaccineT-LymphocyteRecommendationInfluenzaAdultHemagglutinationB-LymphocytesImmunogenicityInfluenza A VirusPathogenPhenotype
Grant awards (53)
ECHO Laboratory Core at Vanderbilt for Integrated Sample Biobanking and Processing$3,800,000
U24 · FY2025 · OD · contact PI
Comparison of High vs. Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant Recipients$1,631,325
U01 · FY2025 · AI · contact PI
IP21-002 Enhanced Surveillance for New Vaccine Preventable Diseases$1,310,557
U01 · FY2025 · IP · contact PI
Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients$794,913
U01 · FY2025 · AI · contact PI
Comparison of High vs. Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant Recipients$1,669,617
U01 · FY2024 · AI · contact PI
IP21-002 Enhanced Surveillance for New Vaccine Preventable Diseases$1,234,285
U01 · FY2024 · IP · contact PI
Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients$828,717
U01 · FY2024 · AI · contact PI
Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients$817,174
U01 · FY2024 · AI · contact PI
IP21-002 Enhanced Surveillance for New Vaccine Preventable Diseases$2,750,000
U01 · FY2023 · IP · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$2,300,000
U01 · FY2023 · IP · contact PI
Comparison of High vs. Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant Recipients$1,815,533
U01 · FY2023 · AI · contact PI
Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients$838,489
U01 · FY2023 · AI · contact PI
Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients$814,262
U01 · FY2023 · AI · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$1,936,000
U01 · FY2022 · IP · contact PI
Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients$913,378
U01 · FY2022 · AI · contact PI
Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients$823,756
U01 · FY2022 · AI · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$1,441,645
U01 · FY2021 · IP · contact PI
Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients$838,428
U01 · FY2021 · AI · contact PI
Adenovirus Types and Acute Respiratory Illness Severity in Children$255,000
R21 · FY2021 · AI · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$1,505,484
U01 · FY2020 · IP · contact PI
Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients$862,770
U01 · FY2020 · AI · contact PI
High vs. Standard Dose Flu Vaccine in Pediatric Solid Organ Transplant Recipients$267,620
R34 · FY2020 · AI · contact PI
Adenovirus Types and Acute Respiratory Illness Severity in Children$212,500
R21 · FY2020 · AI · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$1,000,000
U01 · FY2019 · IP · contact PI
High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients$738,858
U01 · FY2019 · AI · contact PI
ConProject-001$58,724
U01 · FY2019 · AI · contact PI
ConProject-002$18,000
U01 · FY2019 · AI · contact PI
ConProject-003$7,929
U01 · FY2019 · AI · contact PI
Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients$1,584,794
U01 · FY2018 · AI · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$1,226,950
U01 · FY2018 · IP · contact PI
High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients$1,152,136
U01 · FY2018 · AI · contact PI
Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients$1,561,471
U01 · FY2017 · AI · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$1,000,000
U01 · FY2017 · IP · contact PI
High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients$832,698
U01 · FY2017 · AI · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$300,000
U01 · FY2017 · IP · contact PI
Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients$1,711,635
U01 · FY2016 · AI · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$785,699
U01 · FY2016 · IP · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$250,000
U01 · FY2016 · IP · contact PI
Enhanced Surveillance for New Vaccine Preventable Diseases$214,285
U01 · FY2016 · IP · contact PI
NEW VACCINE SURVEILLANCE NETWORK$500,000
U01 · FY2015 · IP · contact PI
NEW VACCINE SURVEILLANCE NETWORK$385,714
U01 · FY2015 · IP · contact PI
NEW VACCINE SURVEILLANCE NETWORK$264,285
U01 · FY2015 · IP · contact PI
NEW VACCINE SURVEILLANCE NETWORK$391,529
U01 · FY2014 · IP · contact PI
NEW VACCINE SURVEILLANCE NETWORK$241,291
U01 · FY2014 · IP · contact PI
NEW VACCINE SURVEILLANCE NETWORK$391,529
U01 · FY2013 · IP · contact PI
NEW VACCINE SURVEILLANCE NETWORK$208,471
U01 · FY2013 · IP · contact PI
NEW VACCINE SURVEILLANCE NETWORK$317,106
U01 · FY2012 · IP · contact PI
NEW VACCINE SURVEILLANCE NETWORK$210,139
U01 · FY2012 · IP · contact PI
NEW VACCINE SURVEILLANCE NETWORK$343,838
U01 · FY2011 · IP · contact PI
NEW VACCINE SURVEILLANCE NETWORK -Patient Protection-ACA$201,220
U01 · FY2011 · IP · contact PI
Neonatal Immunization with Acellular Pertussis Vaccines$124,038
K23 · FY2007 · AI · contact PI
Neonatal Immunization with Acellular Pertussis Vaccines$124,038
K23 · FY2006 · AI · contact PI
Neonatal Immunization with Acellular Pertussis Vaccines$124,038
K23 · FY2005 · AI